Literature DB >> 12746478

Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Anna Wańkowicz-Kalińska1, René M J G J van den Wijngaard, Bert J Tigges, Wiete Westerhof, Graham S Ogg, Vincenzo Cerundolo, Walter J Storkus, Pranab K Das.   

Abstract

Vitiligo is an autoimmune condition characterized by loss of epidermal melanocytes. High frequencies of melanocyte-reactive cytotoxic T cells in the peripheral blood of vitiligo patients and the observed correlation between perilesional T-cell infiltration and melanocyte loss in situ suggest the important role of cellular autoimmunity in the pathogenesis of this disease. We isolated T cells from both perilesional and nonlesional skin biopsies obtained from five vitiligo patients, then cloned and analyzed their profile of cytokine production after short-term, nonspecific expansion in vitro. Perilesional T-cell clones (TCC) derived from patients with vitiligo exhibited a predominant Type-1-like cytokine secretion profile, whereas the degree of Type-1 polarization in uninvolved skin-derived TCC correlated with the process of microscopically observed melanocyte destruction in situ. Detailed analysis of broad spectrum of cytokines produced by perilesional- and nonlesional-derived CD4+ and CD8+ TCC confirmed polarization toward Type-1-like in both CD4 and CD8 compartments, which paralleled depigmentation process observed locally in the skin. Furthermore, CD8+ TCC derived from two patients also were analyzed for reactivity against autologous melanocytes. The antimelanocyte cytotoxic reactivity was observed among CD8+ TCC isolated from perilesional biopsies of two patients with vitiligo. Finally, in two of five patients, tetramer analysis revealed presence of high frequencies of Mart-1-specific CD8 T cells in T-cell lines derived from perilesional skin. Altogether our data support the role of cellular mechanisms playing a significant part in the destruction of melanocytes in human autoimmune vitiligo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746478     DOI: 10.1097/01.lab.0000069521.42488.1b

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  62 in total

1.  Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells.

Authors:  Li Zhou; Kai Li; Yu-Ling Shi; Iltefat Hamzavi; Tian-Wen Gao; Marsha Henderson; Richard H Huggins; Oma Agbai; Bassel Mahmoud; Xiaofan Mi; Henry W Lim; Qing-Sheng Mi
Journal:  Pigment Cell Melanoma Res       Date:  2012-07-12       Impact factor: 4.693

2.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

3.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo.

Authors:  Tara M Kroll; Hemamalini Bommiasamy; Raymond E Boissy; Claudia Hernandez; Brian J Nickoloff; Ruben Mestril; I Caroline Le Poole
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 4.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

5.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

6.  Efficacy of Transplantation of Combination of Noncultured Dermal and Epidermal Cell Suspension vs Epidermal Cell Suspension Alone in Vitiligo: A Randomized Clinical Trial.

Authors:  Vishal Thakur; Sheetanshu Kumar; Muthu Sendhil Kumaran; Hitaishi Kaushik; Niharika Srivastava; Davinder Parsad
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

7.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

8.  Mutant HSP70 reverses autoimmune depigmentation in vitiligo.

Authors:  Jeffrey A Mosenson; Andrew Zloza; John D Nieland; Elizabeth Garrett-Mayer; Jonathan M Eby; Erica J Huelsmann; Previn Kumar; Cecele J Denman; Andrew T Lacek; Frederick J Kohlhapp; Ahmad Alamiri; Tasha Hughes; Steven D Bines; Howard L Kaufman; Andreas Overbeck; Shikhar Mehrotra; Claudia Hernandez; Michael I Nishimura; Jose A Guevara-Patino; I Caroline Le Poole
Journal:  Sci Transl Med       Date:  2013-02-27       Impact factor: 17.956

Review 9.  Innate immune mechanisms in vitiligo: danger from within.

Authors:  Jillian M Richmond; Michael L Frisoli; John E Harris
Journal:  Curr Opin Immunol       Date:  2013-11-12       Impact factor: 7.486

10.  Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo.

Authors:  Mitesh Dwivedi; Naresh C Laddha; Kriti Shah; Bela J Shah; Rasheedunnisa Begum
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.